Moreover, the diverse clinical presentations of prostate cancer underscore the importance of leveraging advanced imaging modalities like PET-PSMA alongside traditional techniques to comprehensively evaluate disease characteristics and tailor treatment strategies accordingly. The gene discussed is FOLH1; the disease is prostate carcinoma.